88,124 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Purchased by Public Sector Pension Investment Board

Public Sector Pension Investment Board bought a new stake in Astrana Health, Inc. (NASDAQ:ASTH) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 88,124 shares of the company’s stock, valued at approximately $5,106,000. Public Sector Pension Investment Board owned approximately 0.18% of Astrana Health at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of ASTH. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in shares of Astrana Health in the third quarter valued at approximately $489,000. MetLife Investment Management LLC purchased a new stake in Astrana Health in the 3rd quarter worth approximately $1,455,000. Bridgewater Associates LP acquired a new position in Astrana Health in the 3rd quarter valued at $952,000. BNP Paribas Financial Markets purchased a new position in shares of Astrana Health during the 3rd quarter worth $573,000. Finally, Quantbot Technologies LP acquired a new stake in shares of Astrana Health during the third quarter worth $244,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Stock Performance

Shares of ASTH stock opened at $43.25 on Monday. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The company has a market cap of $2.43 billion, a PE ratio of 33.27, a P/E/G ratio of 2.00 and a beta of 1.24. The company’s fifty day simple moving average is $52.79 and its 200-day simple moving average is $48.04. Astrana Health, Inc. has a 52 week low of $32.32 and a 52 week high of $63.20.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $478.71 million for the quarter, compared to analysts’ expectations of $462.01 million. During the same quarter in the previous year, the firm posted $0.47 earnings per share. As a group, equities research analysts anticipate that Astrana Health, Inc. will post 1.16 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on ASTH shares. KeyCorp initiated coverage on Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. TD Cowen initiated coverage on shares of Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective on the stock. BTIG Research raised their target price on shares of Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research report on Thursday, October 3rd. Robert W. Baird upped their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Finally, Truist Financial lifted their price target on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a report on Friday, August 9th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $65.17.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.